Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DocGo (DCGO) EBITDA (2020 - 2025)

DocGo has reported EBITDA over the past 6 years, most recently at -$134.1 million for Q4 2025.

  • Quarterly results put EBITDA at -$134.1 million for Q4 2025, down 2979.99% from a year ago — trailing twelve months through Dec 2025 was -$181.2 million (down 1018.61% YoY), and the annual figure for FY2025 was -$181.2 million, down 1018.61%.
  • EBITDA for Q4 2025 was -$134.1 million at DocGo, down from -$28.1 million in the prior quarter.
  • Over the last five years, EBITDA for DCGO hit a ceiling of $23.4 million in Q4 2021 and a floor of -$134.1 million in Q4 2025.
  • Median EBITDA over the past 5 years was $3.5 million (2021), compared with a mean of -$4.7 million.
  • Biggest five-year swings in EBITDA: skyrocketed 173306.44% in 2021 and later tumbled 2979.99% in 2025.
  • DocGo's EBITDA stood at $23.4 million in 2021, then crashed by 63.32% to $8.6 million in 2022, then fell by 3.94% to $8.2 million in 2023, then crashed by 152.8% to -$4.4 million in 2024, then tumbled by 2979.99% to -$134.1 million in 2025.
  • The last three reported values for EBITDA were -$134.1 million (Q4 2025), -$28.1 million (Q3 2025), and -$10.2 million (Q2 2025) per Business Quant data.